Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S Griffith

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Journal of Molecular Endocrinology|September 20, 2012
Therapeutic potential of VIP vs PACAP in diabetesAhter D Sanlioglu, Bahri Karacay, Mustafa Kemal Balci, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
CD8 T cells utilize TRAIL to control influenza virus infectionErik L Brincks, Arna Katewa, Tamara A Kucaba, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2010
Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cellsThomas S Griffith, Erik L Brincks, Prajwal Gurung, et al.
Human Gene Therapy|February 8, 2018
Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 Gene Therapy for DiabetesHale M Tasyurek, Hasan Ali Altunbas, Mustafa Kemal Balci, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2015
Polymicrobial Sepsis Increases Susceptibility to Chronic Viral Infection and Exacerbates CD8+ T Cell ExhaustionStephanie A Condotta, Shaniya H Khan, Deepa Rai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
TRAIL: a mechanism of tumor surveillance in an immune privileged siteHae-Ock Lee, John M Herndon, Ramon Barreiro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2013
Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infectionStephanie A Condotta, Deepa Rai, Britnie R James, et al.
Cancer Immunology, Immunotherapy : CII|April 9, 2014
Effective TRAIL-based immunotherapy requires both plasmacytoid and CD8α dendritic cellsBritnie R James, Erik L Brincks, Tamara A Kucaba, et al.
Journal of Leukocyte Biology|September 3, 2010
TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletionPrajwal Gurung, Tamara A Kucaba, Stephen P Schoenberger, et al.
Islets|April 16, 2013
Clinical utility of insulin and insulin analogsAhter D Sanlioglu, Hasan Ali Altunbas, Mustafa Kemal Balci, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Journal of Molecular Endocrinology|September 20, 2012
Therapeutic potential of VIP vs PACAP in diabetesAhter D Sanlioglu, Bahri Karacay, Mustafa Kemal Balci, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
CD8 T cells utilize TRAIL to control influenza virus infectionErik L Brincks, Arna Katewa, Tamara A Kucaba, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2010
Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cellsThomas S Griffith, Erik L Brincks, Prajwal Gurung, et al.
Human Gene Therapy|February 8, 2018
Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 Gene Therapy for DiabetesHale M Tasyurek, Hasan Ali Altunbas, Mustafa Kemal Balci, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2015
Polymicrobial Sepsis Increases Susceptibility to Chronic Viral Infection and Exacerbates CD8+ T Cell ExhaustionStephanie A Condotta, Shaniya H Khan, Deepa Rai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
TRAIL: a mechanism of tumor surveillance in an immune privileged siteHae-Ock Lee, John M Herndon, Ramon Barreiro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2013
Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infectionStephanie A Condotta, Deepa Rai, Britnie R James, et al.
Cancer Immunology, Immunotherapy : CII|April 9, 2014
Effective TRAIL-based immunotherapy requires both plasmacytoid and CD8α dendritic cellsBritnie R James, Erik L Brincks, Tamara A Kucaba, et al.
Journal of Leukocyte Biology|September 3, 2010
TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletionPrajwal Gurung, Tamara A Kucaba, Stephen P Schoenberger, et al.
Islets|April 16, 2013
Clinical utility of insulin and insulin analogsAhter D Sanlioglu, Hasan Ali Altunbas, Mustafa Kemal Balci, et al.
Pageof 18